16.4% SODIUM ACETATE INJECTION, USP SOLUTION
Country: Canada
Language: English
Source: Health Canada
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
SODIUM ACETATE
Available from:
BAXTER CORPORATION
ATC code:
B05XA08
INN (International Name):
SODIUM ACETATE
Dosage:
16.4%
Pharmaceutical form:
SOLUTION
Composition:
SODIUM ACETATE 16.4%
Administration route:
INTRAVENOUS
Units in package:
250 ML
Prescription type:
Ethical
Therapeutic area:
REPLACEMENT PREPARATIONS
Product summary:
Active ingredient group (AIG) number: 0113986002; AHFS:
Authorization status:
CANCELLED POST MARKET
Authorization date:
2011-05-10
